NIH Awards Sinopia $3.3M to Advance Small Molecule Program

NIH Awards Sinopia $3.3M to Advance Small Molecule Program

307543

NIH Awards Sinopia $3.3M to Advance Small Molecule Program

The National Institutes of Health (NIH) has awarded Sinopia Biosciences $3.3 million to advance the development of its small molecule candidate for Parkinson’s disease. Sinopia will use the grant to move the small molecule forward through investigational new drug (IND)-enabling studies. An IND is a medicine that has been tested in the lab and has been approved by the U.S. Food and Drug Administration (FDA) for testing in clinical trials — those involving humans. “We…

You must be logged in to read/download the full post.